Outcome measure | Variable | Unstandardized Coefficients B | Sig | 95% Confidence Interval | |
---|---|---|---|---|---|
Lower bound | Upper bound | ||||
Haemo-Qol-A total score | NPRS six months | 0.76 | < 0.001 | 0.56 | 0.98 |
Inhibitor status | 4.14 | 0.001 | 1.68 | 6.55 | |
Physical function | NPRS six months | 0.05 | 0.003 | 0.02 | 0.09 |
Factor product | -0.50 | 0.009 | -0.08 | -0.01 | |
On demand treatment | 0.31 | 0.013 | 0.07 | 0.56 | |
Role function | NPRS six months | 0.22 | < 0.001 | 0.16 | 0.28 |
Inhibitor status | 0.85 | 0.018 | 0.15 | 1.55 | |
Worry | NPRS six months | 0.24 | < 0.001 | 0.18 | 0.31 |
Inhibitor status | 0.79 | 0.041 | 0.03 | 1.55 | |
Bleeding | NPRS six months | 0.19 | < 0.001 | 0.12 | 0.25 |
Inhibitor status | 1.04 | 0.005 | 0.30 | 1.79 | |
Emotion | NPRS six months | -0.11 | < 0.001 | -0.162 | -0.06 |
MOXFQ (foot and ankle) total score | NPRS six months | 6.84 | < 0.001 | 5.88 | 7.80 |
Inhibitor status | 11.39 | 0.048 | 0.12 | 22.65 | |
Walking/ standing | NPRS six months | 1.85 | < 0.001 | 1.50 | 2.20 |
HJHS right | 0.23 | 0.021 | 0.04 | 0.43 | |
Pain | NPRS six months | 1.40 | < 0.001 | 1.22 | 1.59 |
Social | NPRS six months | 1.05 | < 0.001 | 0.89 | 1.24 |
Inhibitor status | 2.85 | 0.011 | 0.67 | 5.04 |